1.石家庄市中医院中西医结合科,石家庄 050051
毕俊芳,女,42岁,硕士,副主任医师。研究方向:恶性肿瘤的中西医结合治疗。
扫 描 看 全 文
毕俊芳,张华.补阳还五汤联合艾灸治疗老年晚期肺癌疗效观察[J].北京中医药,2023,42(3):338-342.
BI Jun-fang,ZHANG Hua.Observation on therapeutic effect of Buyang Huanwu Decoction combined with moxibustion on advanced lung cancer in the elderly[J]. Beijing Journal of Traditional Chinese Medicine,2023,42(03):338-342.
毕俊芳,张华.补阳还五汤联合艾灸治疗老年晚期肺癌疗效观察[J].北京中医药,2023,42(3):338-342. DOI: 10.16025/j.1674-1307.2023.03.028.
BI Jun-fang,ZHANG Hua.Observation on therapeutic effect of Buyang Huanwu Decoction combined with moxibustion on advanced lung cancer in the elderly[J]. Beijing Journal of Traditional Chinese Medicine,2023,42(03):338-342. DOI: 10.16025/j.1674-1307.2023.03.028.
目的,2,观察补阳还五汤联合艾灸治疗老年晚期肺癌的疗效。,方法,2,将70例符合纳入标准的患者随机分为治疗组和对照组各35例,均给予抗肿瘤及对症支持治疗,治疗组加补阳还五汤及温和灸,均治疗6周。对比2组中医证候疗效及治疗前后中医证候评分、外周血T淋巴细胞亚群、肺癌患者生存质量量表(FACT-L)评分、凝血及血小板指标[凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)、D-二聚体(D-D)、血小板(PLT)]、安全性。,结果,2,治疗后治疗组中医证候积分为(17.14±2.59)分低于对照组(21.14±2.84)分(,P,<,0.05);治疗组中医证候总有效率(80.0%)优于对照组(51.4%),差异有统计学意义(,P,<,0.05)。治疗后,治疗组CD8,+,T淋巴细胞比例较治疗前及对照组低,其余各项指标均较治疗前及对照组高,差异均有统计学意义(,P,<,0.05);而对照组各项指标治疗前后差异无统计学意义(,P,>,0.05)。治疗后,治疗组除社会/家庭情况评分外,其余各项评分均较治疗前及对照组高(,P,<,0.05);而对照组各项评分治疗前后比较差异均无统计学意义(,P,>,0.05)。治疗后,治疗组APTT、PT延长,较治疗前及对照组高(,P,<,0.05);FIB、PLT、D-D较治疗前及对照组低(,P,<,0.05);而对照组上述指标治疗前后比较差异均无统计学意义(,P,>,0.05)。,结论,2,补阳还五汤联合温和灸能够调节机体的免疫功能,缓解高凝状态;改善气虚血瘀证候,提高生存质量。
Objective,2,To observe the efficacy of Buyang Huanwu Decoction combined with moxibustion in the treatment of advanced lung cancer in the elderly.,Methods,2,70 patients who met the inclusive criteria were randomly divided into treatment group and control group, with 35 patients in each group. All patients were treated with anti-tumor and symptomatic support. The treatment group was treated with Buyang Huanwu Decoction and mild moxibustion for 6 weeks. The efficacy of the two groups and the scores before and after treatment with traditional Chinese medicine syndromes, T-lymphocyte subsets in peripheral blood, quality of life scale scores of lung cancer patients(FACT-L),coagulation and platelet indexes(prothrombin time, PT), activated partial thromboplastin time(APTT), fibrinogen(FIB), D-dimer(D-D), platelet(PLT) and safety were compared.,Results,2,After treatment, the Traditional Chinese medicine syndrome score in the treatment group was(17.14 ± 2.59)points, which was lower than that in the control group(21.14 ± 2.84)points(,P,<,0.05),the total effective rate of the treatment group(80.0%) was better than that of the control group(51.4%), with a statistically significant difference(,P,<,0.05). After treatment, the ratio of CD8,+,T lymphocytes in the treatment group was lower than those in the same group before treatment and the control group after treatment, and the other indexes were higher than those in the same group before treatment and the control group after treatment, with the difference statistically significant(,P,<,0.05).There was no significant difference in the control group before and after treatment(,P,>,0.05). After treatment, except for social/family situation scores, the other scores in the treatment group were higher than those in the treatment group before treatment and the control group after treatment(,P,<,0.05), while there was no significant difference in the scores of the control group before and after treatment(,P,>,0.05).After treatment, APTT and PT in the treatment group were prolonged, which were higher than those in the same group before treatment and the control group after treatment(,P,<,0.05), FIB, PLT, and D-D were lower in the treatment group than those in the same group before treatment and the control group after treatment(P,<,0.05). There was no significant difference in the above indexes before and after treatment in the control group(,P,>,0.05).,Conclusion,2,Buyang Huanwu Decoction combined with mild moxibustion can regulate the body's immune function, relieve hypercoagulable state, improve Qi-deficiency and blood stasis syndrome, andenhance the quality of life.
补阳还五汤艾灸老年晚期肺癌免疫功能高凝状态
Buyang Huanwu Decoctionmoxibustionelderly advanced lung cancerimmune functionhypercoagulable state
ZENKE Y, HAKOZAKI T, NAKAHARA Y, et al. Medical management of older patients with lung cancer[J]. Jpn J Clin Oncol,2022,52(10):1082-1088.
高崇崇, 李非. 我国老年恶性肿瘤发病特点及危险因素分析[J]. 老年医学与保健,2018,24(6):729-731.
王珊珊, 王巍伟, 潘磊,等. 肺癌患者凝血功能变化及其临床意义[J]. 标记免疫分析与临床,2020,27(10):1637-1641.
段桦, 周天, 胡凯文. 益气活血法在恶性肿瘤治疗中的应用及其作用机制研究概况[J]. 中医杂志,2020,61(2):169-173.
中华医学会, 中华医学会肿瘤学分会, 中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2018版)[J]. 肿瘤研究与临床,2018,30(12):793-824.
郑洋,孙霈,董青,等.恶性肿瘤高凝状态发病机制与诊断标准探讨[J].中国医刊,2014,49(5):16-20.
郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:378-383.
陈家旭.中医诊断学[M].北京:中国中医药出版社,2015:148.
KAY FU, KANDATHIL A, BATRA K, et al. Revisions to the tumor, node, metastasis staging of lung cancer (8th edition): Rationale, radiologic findings and clinical implications[J]. World J Radiol,2017,9(6):269-279.
MIYAHARA T, SUEOKA-ARAGANE N, IWANAGA K, et al. Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer[J]. Med Oncol,2017,34(12):195.
CAMPELLO E, HENDERSON MW, NOUBOUOSSIE DF, et al. Contact system activation and cancer: new insights in the pathophysiology of cancer-associated thrombosis[J]. Thromb Haemost,2018,118(2):251-265.
FREI AN, STALDER O, LIMACHER A, et al. Comparison of bleeding risk scores in elderly patients receiving extended anticoagulation with vitamin K antagonists for venous thromboembolism[J]. Thromb Haemost,2021,121(11):1512-1522.
周飘, 杜全宇, 王飞. 益气活血类中药复方干预恶性肿瘤血行转移机制的研究进展[J]. 中国实验方剂学杂志,2022,28(1):226-233.
韩全乡, 王磊, 胡应亮,等. 补阳还五汤对肺癌脑转移瘤患者T淋巴细胞亚群、血清CEA及LDH水平的影响[J]. 中医药信息,2022,39(5):70-73.
向璐, 张巧艳, 赵琦明,等. 黄芪-当归化学成分、药理作用及临床应用的研究进展[J]. 中草药,2022,53(7):2196-2213.
吴娅丽, 马韫楠, 杜守颖. 中药地龙抗血栓活性研究进展[J]. 中华中医药杂志,2020,35(6):3015-3018.
张晓娟, 张燕丽, 左冬冬. 川芎的化学成分和药理作用研究进展[J]. 中医药信息,2020,37(6):128-133.
吴玲芳, 王子墨, 赫柯芊,等. 赤芍的化学成分和药理作用研究概况[J]. 中国实验方剂学杂志,2021,27(18):198-206.
王佐梅, 肖洪彬, 李雪莹,等. 中药红花的药理作用及临床应用研究进展[J]. 中华中医药杂志,2021,36(11):6608-6611.
吴雨, 王玉娟, 李明,等. 灸法治疗肿瘤的免疫机制研究进展[J]. 针刺研究,2020,45(1):83-86,封3.
NAGASAKI J, TOGASHI Y. A variety of 'exhausted' T cells in the tumor microenvironment[J]. Int Immunol, 2022,34(11):563-570.
吴代强, 周华, 周建英. 老年肺癌合并血液高凝状态患者的临床特征[J]. 中国老年学杂志,2017,37(17):4295-4297.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构